Literature DB >> 78616

Syringocystadenoma papilliferum: light and electron microscopic studies.

K Niizuma.   

Abstract

Light microscopic and electron microscopic studies of a lesion displaying a typical histopathological picture of syringocystadenoma papilliferum (S.P.) are reported. Light microscopic serial sections showed that the tumor parenchyma extended to the epithelium just above the intrafollicular sebaceous duct. The tumor thus presumably develops from the epithelial region corresponding to the intrafollicular duct of the apocrine sweat gland. Electron microscopy revealed a non-keratinized intracytoplasmic cavity and intercellular canaliculi apparently formed as a continuation of this cavity. Keratinized cells were absent from the glandular and duct epithelium and even from the superficial epithelial portion of acanthotic areas. Neither myoepithelial cells nor secretory granules were identified in areas showing tubular, glandular, or sinusoidal structures. It was concluded that the tumor differentiates towards both the intrafollicular and intradermal duct of the embryonic apocrine sweat gland apparatus.

Entities:  

Mesh:

Year:  1976        PMID: 78616

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  Localization of transforming growth factor-alpha in human appendageal tumors.

Authors:  E Finzi; T Ho; G Anhalt; W Hawkins; R Harkins; T Horn
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Chemoradiotherapy in a Case of Malignant Syringocystadenocarcinoma Papilliferum of Vulva with Locoregional Failure.

Authors:  Pamidimukkala Bramhananda Rao; Saptarshi Ghosh; Manisha Mohapatra; N Pramod Philip; P Ravindra Kumar; Surendra Manam; Pradeep Karra; Vijay Krishna Jasti
Journal:  Case Rep Oncol Med       Date:  2015-11-30

3.  Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.

Authors:  Dong Xu; Tienan Bi; Huanrong Lan; Wenjie Yu; Wenmin Wang; Feilin Cao; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-26       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.